Log In
Print
BCIQ
Print
Print this Print this
 

FV-100

  Manage Alerts
Collapse Summary General Information
Company ContraVir Pharmaceuticals Inc.
DescriptionOral bicyclic nucleoside analog
Molecular Target Not available
Mechanism of ActionAntiviral agent
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationVaricella zoster virus (VZV)
Indication DetailsTreat Varicella zoster virus (VZV) infection (shingles)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today